Bukwang Pharmaceutical Co., Ltd.

₩3,800As of Sun 8 Nov 2026, 12:00 UTC
KRX:003000Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (9.80%)
Div yield 3.95%
ROE 2.98%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.09
PE TTM 42.43
TSR TTM 6.36%
Mkt cap ₩374.9B
ROIC 5.17%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩3,973
4.54%
(60.76%)
Hold 7|9|11|2|8
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
46.53
50.70
53.42
57.77
28.42%
28.53%
33.33%
29.11%
Revenue₩B
20.77
21.66
21.43
21.31
17.29%
22.42%
15.27%
8.68%
Peers (US$276.4M)
Cap (US$)
PE
239.8M
37.98x
275.7M
29.33x
Capital
TTM
5Y
10Y
Leveragex
1.162
0.112
0.083
EBIT/Intx
1.032
0.555
0.464
Own earn%
20.25
280.15
279.14
Sh yield%
39.42
44.24
42.98
Owners
Insiders/Inst%
10.58
39.14
Short interest%
4.92
SBC / revenue%
1.85
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
23–27
$1 testx
0.0
Incr. ROIC%
11